Vhura Precision Kurapwa kweNSCLC neAdvanced EGFR Mutation Testing

Chirwere chegomarara remapapu chinoramba chiri dambudziko rehutano hwepasirese, rinomira sechipiri kenza inowanzo zivikanwa. Muna 2020 chete, pakanga paine nyaya nyowani dzinopfuura mamirioni maviri nemazana maviri pasi rese. Isiri diki-diki kenza yemapapu (NSCLC) inomiririra zvinopfuura makumi masere muzana ezvese zvinoongororwa kenza yemapapu, zvichiratidza kudiwa kwekukurumidzira kweanonangwa uye anoshanda nzira dzekurapa.

EGFR shanduko dzakabuda sedombo repakona mukurapwa kwemunhu kweNSCLC. EGFR tyrosine kinase inhibitors (TKIs) inopa nzira yekuchinja nekuvhara masaini ekutyaira kenza, kuvharidzira kukura kwebundu, uye kukurudzira kufa kwekenza - zvese izvi zvichideredza kukuvadzwa kwemaseru ane hutano.

Inotungamira nhungamiro yekiriniki, kusanganisira iyo NCCN, ikozvino inoraira EGFR shanduko yekuongorora isati yatanga kurapa kweTKI, kuve nechokwadi kuti varwere vakakwana vanowana mishonga chaiyo kubva pakutanga.

EGFR shanduko dzakabuda sedombo repakona mukurapwa kwemunhu kweNSCLC. EGFR tyrosine kinase inhibitors (TKIs) inopa nzira yekuchinja nekuvhara masaini ekutyaira kenza, kuvharidzira kukura kwebundu, uye kukurudzira kufa kwekenza - zvese izvi zvichideredza kukuvadzwa kwemaseru ane hutano.

Inotungamira nhungamiro yekiriniki, kusanganisira iyo NCCN, ikozvino inoraira EGFR shanduko yekuongorora isati yatanga kurapa kweTKI, kuve nechokwadi kuti varwere vakakwana vanowana mishonga chaiyo kubva pakutanga.

Kusuma Human EGFR Gene 29 Mutations Detection Kit (Fluorescence PCR)
Precision Detection yeConfid Treatment Sarutions

Macro & Micro-Test's EGFR yekuongorora kit inogonesa kukurumidza uye kwakaringana kuzivikanwa kwemakumi maviri nemapfumbamwe ekuchinja kwekuchinja kune ese maexons 18-21 mune ese ari maviri matissue uye emvura biopsies- ichipa varapi simba kuti vagadzirise kurapwa nechivimbo.

Sei SarudzaMacro & Micro-Muedzo'sEGFR Testing Kit?

Iyo kit inoona 29 yakajairika EGFR gene mutations mune exons 18-21 kubva munyama kana ropa samples dzevarwere veNSCLC, inovhara zvinodhaka senitivity uye nzvimbo dzekupikisa kutungamira kushandiswa kwezvinodhaka zvakanangwa segefitinib uye osimertinib.

1. 1.Improved ARMS Technology: Enhanced ARMS ine patented enhancer yemhando yepamusoro;
2. 2.Enzymatic Enrichment: Inoderedza mamiriro emusango-mhando ne enzymatic digestion, kuvandudza kutaridzika kwekuona uye kuderedza kusinganzwisisi amplification nekuda kwepamusoro genomic background;
3. 3.Temperature Kuvhara: Inowedzera matanho chaiwo ekupisa muPCR maitiro, kuderedza kusawirirana uye kuwedzera kunyatsoona;
4. 4.High Sensitivity: Inoona shanduko dzakaderera se1% mutation;
5. 5.Great Accuracy: Kudzora kwemukati uye UNG enzyme kuderedza migumisiro yenhema;
6. 6.Kubudirira: Zvinangwa zvinoguma mukati me120 min
7. 7.Dual Sample Support - Yakagadziridzwa kune ese matissue uye eropa samples, ichipa kuchinjika mukuita kwekiriniki.
8. 8.Wide kugarisana: Inopindirana zvakanyanya neyakajairwa PCR zviridzwa pamusika;
9. 9.Sherufu-hupenyu: 12 mwedzi.

Tungamira Therapy with Confidence
Iyo kiti inobatsira kukwirisa mhedzisiro yekiriniki uye kuramba uri pamberi pekupokana nekunzwa kwakanyanya uye kuramba shanduko.

Wedzera Yako Precision Oncology Portfolio
Ongorora huwandu hwedu hwakazara hwemhinduro dzekuona shanduko yeKRAS, BRAF, ROS1, ALK, BCR-ABL, TEL-AML1, nezvimwe- zvese zvakagadzirirwa kutsigira yakazara biomarker-inofambiswa nehanya.

Dzidza zvimwe:https://www.mmtest.com/oncology/

Contact our team: marketing@mmtest.com